Gastroenterology Education and CPD for trainees and specialists » Severe Vasculitis Yields to Rituximab (CME/CE)

- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -

Severe Vasculitis Yields to Rituximab (CME/CE)

(MedPage Today) — The B-cell depleting agent rituximab (Rituxan) effectively alleviates serious manifestations of cryoglobulinemic vasculitis, two groups of researchers found.

Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com